跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,214 条关于
“NanoSpark® GROW-NK Soluble Activator”
全部
31,214
临床试验
24,675
药物
1,713
机构
18
资讯
4,808
去年
Sartorius Stedim Biotech Partners with Nanotein Technologies to Enhance Cell Therapy Manufacturing with NanoSpark® Platform
2年前
Bayer's Phase II Trial of BAY3283142 Aims to Treat Chronic Kidney Disease
去年
Exelixis Initiates Phase 1 Trial of XB628, a Novel Bispecific NK Cell Engager for Advanced Solid Tumors
7个月前
NK Cell Engager Development Faces Mounting Setbacks as BeOne Medicines and Novartis Discontinue Programs
去年
INmune Bio Completes Enrollment in Phase 2 Alzheimer's Trial and Reports Positive NK-Cell Data in Prostate Cancer Study
去年
Bayer Advances Pharma Pipeline with Regulatory Filings and Clinical Milestones
去年
Lecanemab Demonstrates Superior Binding to Soluble Amyloid-beta Aggregates Compared to Other Antibodies
去年
Cellistic Launches Echo-NK Platform for Scalable Allogeneic NK Cell Therapy Manufacturing
去年
Weight Loss Market Booms as Pharma Responds to Obesity Crisis
去年
Innate Pharma's Novel NK Cell Engager IPH6501 to Be Presented at EHA 2025 Congress
第 1 页，共 481 页
上一页
下一页
